Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-000925
Filing Date
2021-03-12
Accepted
2021-03-12 17:11:16
Documents
63
Period of Report
2021-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pharmacyte_10q-013121.htm 10-Q 539275
2 CORPORATE BY-LAWS AS AMENDED BY AMENDMENT NO.1 AND NO.2 pharmacyte_ex0302.htm EX-3.2 89729
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER pharmacyte_ex3101.htm EX-31.1 9227
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER pharmacyte_ex3102.htm EX-31.2 9321
5 CERTIFICATION pharmacyte_ex3201.htm EX-32.1 4561
6 CERTIFICATION pharmacyte_ex3202.htm EX-32.2 5063
  Complete submission text file 0001683168-21-000925.txt   3576098

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE pmcb-20210131.xml EX-101.INS 713013
8 XBRL SCHEMA FILE pmcb-20210131.xsd EX-101.SCH 37681
9 XBRL CALCULATION FILE pmcb-20210131_cal.xml EX-101.CAL 43400
10 XBRL DEFINITION FILE pmcb-20210131_def.xml EX-101.DEF 162791
11 XBRL LABEL FILE pmcb-20210131_lab.xml EX-101.LAB 261106
12 XBRL PRESENTATION FILE pmcb-20210131_pre.xml EX-101.PRE 237572
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 333-68008 | Film No.: 21738441
SIC: 2836 Biological Products, (No Diagnostic Substances)